Selected 2003 Public Offerings

Selected 2003 Public Offerings

Publication

In 2003, we handled more than 40 public offerings and Rule 144A placements valued in excess of $5 billion. In the past five years, we have participated in more than 200 public offerings and Rule 144A placements raising over $40 billion. The following are selected highlights from our 2003 transactions:

  • Acusphere — Initial Public Offering of Common Stock – $52,500,000 — Counsel to Underwriters
  • Akamai — Rule 144A Placement of 1.0% Senior Convertible Notes — $175,000,000 — Counsel to Issuer
  • American Superconductor — Follow-On Offering of Common Stock — $54,351,875 — Counsel to Issuer
  • Casella Waste Systems, Inc. – Rule 144A Placement of 9.75% Senior Subordinated Notes — $150,000,000 — Counsel to Issuer
  • Centene Corporation — Follow-On Offering of Common Stock — $86,250,000 — Counsel to Issuer
  • CollaGenex Pharmaceuticals — Follow-On Offering of Common Stock — $20,000,000 – Counsel to Issuer
  • Cubist Pharmaceuticals — Follow-On Offering of Common Stock — $90,000,000 — Counsel to Underwriters
  • Cytogen — Follow-On Offering of Common Stock — $20,500,000 — Counsel to Issuer
  • DoubleClick — Rule 144A Placement of Zero Coupon Convertible Subordinated Notes — $135,000,000 — Counsel to Issuer
  • Epix Medical — Follow-On Offering of Common Stock — $69,675,000 — Counsel to Underwriters
  • First Marblehead — Initial Public Offering of Common Stock — $213,900,000 — Counsel to Issuer
  • John Hancock — Public Offerings of Common Stock and Preferred Stock of Closed-End Funds — $1,544,625,000 — Counsel to Issuer
  • Keane — Rule 144A Placement of 2% Convertible Subordinated Debentures — $150,000,000 – Counsel to Issuer
  • LCC — Follow-On Offering of Common Stock — $33,005,000 — Counsel to Underwriters
  • Lexicon — Follow-On Offering of Common Stock — $49,350,000 — Counsel to Underwriters
  • Lincare — Rule 144A Placement of 3.00% Convertible Senior Debentures — $275,000,000 — Counsel to Issuer
  • LIN Television Corporation — Rule 144A Placement of 2.50% Exchangeable Senior Subordinated Debentures — $125,000,000 — Counsel to Issuer
  • LIN Television Corporation — Rule 144A Placement of 6 ½% Senior Subordinated Notes — $200,000,000 — Counsel to Issuer
  • nCipher — Public Distribution and Repurchase of Redeemable Preference Shares — £65,000,000 — Counsel to Issuer
  • NitroMed — Initial Public Offering of Common Stock — $61,380,000 — Counsel to Issuer
  • Nortel Networks — Secondary Offering of Common Stock of ARRIS Group, Inc. — $49,050,000 — Counsel to Nortel
  • Ocean Power Technologies, Inc . — Initial Public Offering of Common Stock — £25,000,000 – Counsel to Issuer
  • Open Solutions — Initial Public Offering of Common Stock — $87,946,080 — Counsel to Issuer
  • Pioneer Investments — Public Offerings of Common Stock and Preferred Stock of Closed-End Funds — $961,625,000 — Counsel to Issuer
  • Progenics Pharmaceuticals, Inc . — Follow-On Offering of Common Stock — $54,153,125 — Counsel to Underwriters
  • PS Business Parks — Follow-On Offering of Common Stock — $111,379,805 — Counsel to Underwriters
  • Sepracor — Rule 144A Placement of 0% Convertible Senior Subordinated Notes — $750,000,000 — Counsel to Issuer
  • SRA International, Inc. — Follow-On Offering of Common Stock — $104,362,500 — Counsel to Issuer
  • Staples — Follow-On Offering of Common Stock — $252,861,540 — Counsel to Issuer
  • The Medicines Company — Follow-On Offering of Common Stock — $97,952,400 — Counsel to Issuer
  • Wolfson Microelectronics — Initial Public Offering of Ordinary Shares — £79,500,000 – Counsel to Issuer
  • Yankee Candle — Secondary Offering of Common Stock — $216,626,644 — Counsel to Issuer

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.